Anupam Rama
Analyst
J.P. Morgan
Equibles does not estimate personal net worth.
About Anupam Rama
Anupam Rama is recorded as Analyst at J.P. Morgan. Anupam Rama has spoken on 15 earnings calls and 4 other investor events across 10 companies, most recently for BridgeBio Pharma, Inc. on October 29, 2026. Those appearances were for BridgeBio Pharma, Inc. (BBIO), Travere Therapeutics, Inc. (TVTX), Sarepta Therapeutics, Inc. (SRPT), Ultragenyx Pharmaceutical Inc. (RARE), Zai Lab Ltd (ZLAB) and 5 other companies. The companies whose calls Anupam Rama spoke on are classified in the Healthcare sector.
Anupam Rama on recent calls
“On 418 in Europe, hold on, that's Kazimov messing with me. On 418 in Europe, you noted today that you're now planning on submitting an MMA in the first half of 28, based on your interactions with health authorities.”
“The press release talked about shipping to qualified centers in the next 30 to 60 days. Can you talk a little bit about how many centers of excellence we're talking about here that are equipped for infusions today and how that could grow over time?”
“And congratulations as well on the approval. I just wanted to ask what triggers the full approval? do you have to wait for the two years for the safety and efficacy data from the 50 patients and 20 control?”
“Just looking to ESMO, can you walk us through what you're looking for in the first-line small cell study of ZOSI plus IO plus or minus chemo? Like, what's going to be the size and scope of that data set, and how are you defining a win scenario?”
Affiliation history
-
J.P. Morgan
Analyst
Source not stated
Current
Company network
ZLAB
Biotechnology · Healthcare
Drug Manufacturers - Specialty & Generic · Healthcare
Drug Manufacturers - Specialty & Generic · Healthcare
Apellis Pharmaceuticals, Inc.
Biotechnology · Healthcare
Recent activity
Show 7 earlier activities
-
-
-
-
-
Earnings call
Apellis Pharmaceuticals, Inc. Q4 FY2025 Earnings Call
Apellis Pharmaceuticals, Inc.
-
-